AU2003290518A8 - Methods and compositions concerning designed highly-specific nucleic acid binding proteins - Google Patents

Methods and compositions concerning designed highly-specific nucleic acid binding proteins

Info

Publication number
AU2003290518A8
AU2003290518A8 AU2003290518A AU2003290518A AU2003290518A8 AU 2003290518 A8 AU2003290518 A8 AU 2003290518A8 AU 2003290518 A AU2003290518 A AU 2003290518A AU 2003290518 A AU2003290518 A AU 2003290518A AU 2003290518 A8 AU2003290518 A8 AU 2003290518A8
Authority
AU
Australia
Prior art keywords
methods
nucleic acid
binding proteins
acid binding
specific nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003290518A
Other versions
AU2003290518A1 (en
Inventor
Meggan Chadsey
Brett Chevalier
Raymond J Monnat Jr
Tania Kortemme
Barry L Stoddard
David Baker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fred Hutchinson Cancer Center
Original Assignee
Fred Hutchinson Cancer Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fred Hutchinson Cancer Research Center filed Critical Fred Hutchinson Cancer Research Center
Publication of AU2003290518A8 publication Critical patent/AU2003290518A8/en
Publication of AU2003290518A1 publication Critical patent/AU2003290518A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
AU2003290518A 2002-09-06 2003-09-05 Methods and compositions concerning designed highly-specific nucleic acid binding proteins Abandoned AU2003290518A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40884702P 2002-09-06 2002-09-06
US60/408,847 2002-09-06
PCT/US2003/027875 WO2004031346A2 (en) 2002-09-06 2003-09-05 Methods and compositions concerning designed highly-specific nucleic acid binding proteins

Publications (2)

Publication Number Publication Date
AU2003290518A8 true AU2003290518A8 (en) 2004-04-23
AU2003290518A1 AU2003290518A1 (en) 2004-04-23

Family

ID=32069688

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003290518A Abandoned AU2003290518A1 (en) 2002-09-06 2003-09-05 Methods and compositions concerning designed highly-specific nucleic acid binding proteins

Country Status (2)

Country Link
AU (1) AU2003290518A1 (en)
WO (1) WO2004031346A2 (en)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009095742A1 (en) 2008-01-31 2009-08-06 Cellectis New i-crei derived single-chain meganuclease and uses thereof
EP1591521A1 (en) 2004-04-30 2005-11-02 Cellectis I-Dmo I derivatives with enhanced activity at 37 degrees C and use thereof
WO2007034262A1 (en) * 2005-09-19 2007-03-29 Cellectis Heterodimeric meganucleases and use thereof
ATE466933T1 (en) * 2005-03-15 2010-05-15 Cellectis I-CREI MEGANUCLEASE VARIANTS WITH MODIFIED SPECIFICITY AND METHOD FOR THEIR PRODUCTION AND USE
CA2626262C (en) 2005-10-18 2015-09-08 Homme W. Hellinga Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity
WO2007060495A1 (en) 2005-10-25 2007-05-31 Cellectis I-crei homing endonuclease variants having novel cleavage specificity and use thereof
WO2007049095A1 (en) 2005-10-25 2007-05-03 Cellectis Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof
WO2008093152A1 (en) * 2007-02-01 2008-08-07 Cellectis Obligate heterodimer meganucleases and uses thereof
CN101784658A (en) 2007-06-06 2010-07-21 赛莱克蒂斯公司 Enhancing is from the method for the nicking activity of the meganuclease of I-CreI
CA2691440A1 (en) 2007-06-29 2009-01-08 Pioneer Hi-Bred International, Inc. Methods for altering the genome of a monocot plant cell
WO2009013559A1 (en) 2007-07-23 2009-01-29 Cellectis Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
WO2009114321A2 (en) 2008-03-11 2009-09-17 Precision Biosciencs, Inc. Rationally-designed meganucleases for maize genome engineering
WO2010001189A1 (en) * 2008-07-03 2010-01-07 Cellectis The crystal structure of i-dmoi in complex with its dna target, improved chimeric meganucleases and uses thereof
EP4001408A3 (en) 2008-07-14 2022-06-08 Precision Biosciences, Inc. Recognition sequences for i-crei-derived meganucleases and uses thereof
WO2010136981A2 (en) 2009-05-26 2010-12-02 Cellectis Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
WO2011007193A1 (en) 2009-07-17 2011-01-20 Cellectis Viral vectors encoding a dna repair matrix and containing a virion-associated site specific meganuclease for gene targeting
WO2011021062A1 (en) 2009-08-21 2011-02-24 Cellectis Meganuclease variants cleaving a dna target sequence from the human lysosomal acid alpha-glucosidase gene and uses thereof
WO2011064751A1 (en) * 2009-11-27 2011-06-03 Basf Plant Science Company Gmbh Chimeric endonucleases and uses thereof
JP5922029B2 (en) * 2009-11-27 2016-05-24 ビーエーエスエフ プラント サイエンス カンパニー ゲーエムベーハー Chimeric endonuclease and use thereof
US8704041B2 (en) 2009-12-30 2014-04-22 Pioneer Hi Bred International Inc Methods and compositions for targeted polynucleotide modification
WO2011101696A1 (en) 2010-02-18 2011-08-25 Cellectis Improved meganuclease recombination system
WO2011141820A1 (en) 2010-05-12 2011-11-17 Cellectis Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof
EP2569435A1 (en) 2010-05-12 2013-03-20 Cellectis Meganuclease variants cleaving a dna target sequence from the rhodopsin gene and uses thereof
EP2582845A2 (en) 2010-06-15 2013-04-24 Cellectis Method for improving cleavage of dna by endonuclease sensitive to methylation
EP2591098A2 (en) 2010-07-07 2013-05-15 Cellectis Meganucleases variants cleaving a dna target sequence in the nanog gene and uses thereof
WO2012010976A2 (en) 2010-07-15 2012-01-26 Cellectis Meganuclease variants cleaving a dna target sequence in the tert gene and uses thereof
WO2012007848A2 (en) 2010-07-16 2012-01-19 Cellectis Meganuclease variants cleaving a dna target sequence in the was gene and uses thereof
SG189482A1 (en) 2010-10-27 2013-05-31 Cellectis Method for increasing the efficiency of double-strand break-induced mutagenesis
MX2013010911A (en) 2011-03-23 2015-03-03 Pioneer Hi Bred Int Methods for producing a complex transgenic trait locus.
WO2012138901A1 (en) 2011-04-05 2012-10-11 Cellectis Sa Method for enhancing rare-cutting endonuclease efficiency and uses thereof
US20140115726A1 (en) 2011-04-05 2014-04-24 Cellectis New tale-protein scaffolds and uses thereof
SG194089A1 (en) 2011-04-27 2013-11-29 Amyris Inc Methods for genomic modification
BR112013030652A2 (en) * 2011-06-10 2016-12-13 Basf Plant Science Co Gmbh polynucleotide encoding a polypeptide, nucleic acid molecule, vector, non-human organism, polypeptide and method for introducing a nucleic acid of interest into a genome of a non-human organism
MX2013015174A (en) 2011-06-21 2014-09-22 Pioneer Hi Bred Int Methods and compositions for producing male sterile plants.
EP2729567B1 (en) 2011-07-08 2016-10-05 Cellectis Method for increasing the efficiency of double-strand break-induced mutagenssis
WO2013019411A1 (en) 2011-08-03 2013-02-07 E. I. Du Pont De Nemours And Company Methods and compositions for targeted integration in a plant
WO2013166113A1 (en) 2012-05-04 2013-11-07 E. I. Du Pont De Nemours And Company Compositions and methods comprising sequences having meganuclease activity
WO2014130706A1 (en) 2013-02-20 2014-08-28 Regeneron Pharmaceuticals, Inc. Genetic modification of rats
UA123532C2 (en) 2013-03-12 2021-04-21 Е. І. Дю Пон Де Немур Енд Компані Methods for the identification of variant recognition sites for rare-cutting engineered double-strand-break-inducing agents and compositions and uses thereof
LT3456831T (en) 2013-04-16 2021-09-10 Regeneron Pharmaceuticals, Inc. Targeted modification of rat genome
WO2015088643A1 (en) 2013-12-11 2015-06-18 Regeneron Pharmaceuticals, Inc. Methods and compositions for the targeted modification of a genome
ES2700596T3 (en) 2013-12-11 2019-02-18 Regeneron Pharma Methods and compositions for the targeted modification of a genome
CN106029886B (en) 2013-12-19 2021-02-05 阿迈瑞斯公司 Method for genomic integration
ES2784754T3 (en) 2014-06-06 2020-09-30 Regeneron Pharma Methods and compositions to modify a target locus
SI3354732T1 (en) 2014-06-23 2020-07-31 Regeneron Pharmaceuticals, Inc. Nuclease-mediated dna assembly
SI3161128T1 (en) 2014-06-26 2019-02-28 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modifications and methods of use
EP3561052A1 (en) 2014-10-15 2019-10-30 Regeneron Pharmaceuticals, Inc. Methods and compositions for generating or maintaining pluripotent cells
CN107208113A (en) 2014-12-19 2017-09-26 瑞泽恩制药公司 Method and composition for carrying out targeting genetic modification by the multiple targeting of single step
EP4219731A3 (en) 2016-05-18 2023-08-09 Amyris, Inc. Compositions and methods for genomic integration of nucleic acids into exogenous landing pads
KR20190041476A (en) 2016-07-29 2019-04-22 리제너론 파마슈티칼스 인코포레이티드 A mouse containing a mutation inducing the expression of C-truncated fibrilin-1
CN111511199A (en) 2017-08-29 2020-08-07 科沃施种子欧洲股份两合公司 Improved blue paste and other separation system
CN111163633B (en) 2017-09-29 2022-09-09 瑞泽恩制药公司 Non-human animals comprising humanized TTR loci and methods of use thereof
KR20200071198A (en) 2018-12-10 2020-06-19 네오이뮨텍, 인코퍼레이티드 Development of new adoptive T cell immunotherapy by modification of Nrf2 expression
KR20210105914A (en) 2018-12-20 2021-08-27 리제너론 파마슈티칼스 인코포레이티드 Nuclease-mediated repeat expansion
JP7065260B2 (en) 2019-04-04 2022-05-11 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Methods for Scarless Introduction of Targeted Modifications to Targeting Vectors
SG11202108454RA (en) 2019-04-04 2021-09-29 Regeneron Pharma Non-human animals comprising a humanized coagulation factor 12 locus
EP3801011A1 (en) 2019-06-04 2021-04-14 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use
CN113939595A (en) 2019-06-07 2022-01-14 瑞泽恩制药公司 Non-human animals including humanized albumin loci
WO2021108363A1 (en) 2019-11-25 2021-06-03 Regeneron Pharmaceuticals, Inc. Crispr/cas-mediated upregulation of humanized ttr allele
WO2022240846A1 (en) 2021-05-10 2022-11-17 Sqz Biotechnologies Company Methods for delivering genome editing molecules to the nucleus or cytosol of a cell and uses thereof
WO2022251644A1 (en) 2021-05-28 2022-12-01 Lyell Immunopharma, Inc. Nr4a3-deficient immune cells and uses thereof
EP4347826A1 (en) 2021-06-02 2024-04-10 Lyell Immunopharma, Inc. Nr4a3-deficient immune cells and uses thereof
WO2023064924A1 (en) 2021-10-14 2023-04-20 Codiak Biosciences, Inc. Modified producer cells for extracellular vesicle production
WO2023129974A1 (en) 2021-12-29 2023-07-06 Bristol-Myers Squibb Company Generation of landing pad cell lines
WO2023220603A1 (en) 2022-05-09 2023-11-16 Regeneron Pharmaceuticals, Inc. Vectors and methods for in vivo antibody production
WO2023225665A1 (en) 2022-05-19 2023-11-23 Lyell Immunopharma, Inc. Polynucleotides targeting nr4a3 and uses thereof
WO2024064958A1 (en) 2022-09-23 2024-03-28 Lyell Immunopharma, Inc. Methods for culturing nr4a-deficient cells
WO2024064952A1 (en) 2022-09-23 2024-03-28 Lyell Immunopharma, Inc. Methods for culturing nr4a-deficient cells overexpressing c-jun
WO2024077174A1 (en) 2022-10-05 2024-04-11 Lyell Immunopharma, Inc. Methods for culturing nr4a-deficient cells

Also Published As

Publication number Publication date
WO2004031346A2 (en) 2004-04-15
AU2003290518A1 (en) 2004-04-23
WO2004031346A3 (en) 2006-10-26

Similar Documents

Publication Publication Date Title
AU2003290518A8 (en) Methods and compositions concerning designed highly-specific nucleic acid binding proteins
PL373962A1 (en) Methods and compositions for analyzing proteins
ZA200601653B (en) Binding constructs and methods for use thereof
AU2003239129A8 (en) Methods and compositions for dna manipulation
EP1424392A4 (en) Novel secretory proteins and dna thereof
PT1752470E (en) Gag binding proteins
HUP0501021A2 (en) Methods and compositions for analyzing proteins
IL162274A (en) Nucleic acid and protein designated 193p1e1b and compositions containing the same
IL174689A0 (en) Native immunoglobulin binding reagents and methods for making and using same
IL170080A (en) Nucleic acid and protein named 158p1d7 and pharmaceutical compositions containing the same
AU2003303588A1 (en) Methods and compositions for sequencing nucleic acid molecules
EP1436233A4 (en) Metal binding proteins and associated methods
GB0609747D0 (en) Protein binding miniature proteins
AU2003284127A8 (en) Nucleic acid supported protein complementation
AU2002311759A8 (en) Methods and compositions for analyzing nucleic acids
HK1080089A1 (en) Rhamnose binding protein
PL379564A1 (en) Btl-ii nucleic acids, proteins, and antibodies
EP1498486A4 (en) Nucleic acid library and protein library
AU2002316178A1 (en) Compositions and methods for binding agglomeration proteins
EP1692155A4 (en) System and methods for nucleic acid and polypeptide selection
GB0119446D0 (en) Binding proteins
AU2003265635A8 (en) Nphp nucleic acids and proteins
AU2003222173A1 (en) Nucleic acid compositions and methods for use
AU2003258658A1 (en) Improved dna and proteins
EP1602666A4 (en) Novel protein and its dna

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase